2041 — Medcaptain Medical Technology Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for Medcaptain Medical Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Revenue
Total Revenue	1,313	1,399	1,619
Cost of Revenue
Gross Profit	651	695	870
Selling / General / Administrative Expenses
Research And Development
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,340	1,453	1,522
Operating Profit	-27.1	-53.6	97
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-49.8	-70.5	78.7
Provision for Income Taxes
Net Income After Taxes	-64.5	-96.6	50.7
Minority Interest
Net Income Before Extraordinary Items
Net Income	-63.7	-96.4	48.9
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-63.7	-96.4	48.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.116	-0.156	0.104